DOI QR코드

DOI QR Code

Successful Treatment of a Korean Infant with Giant Cell Hepatitis with Autoimmune Hemolytic Anemia Using Rituximab

  • Kim, Young Ho (Department of Pediatrics, Seoul National University Hospital) ;
  • Kim, Ju Whi (Department of Pediatrics, Seoul National University Hospital) ;
  • Lee, Eun Joo (Department of Pediatrics, Seoul National University Hospital) ;
  • Kang, Gyeong Hoon (Department of Pathology, Seoul National University Hospital) ;
  • Kang, Hyoung Jin (Department of Pediatrics, Seoul National University College of Medicine, Seoul National University Cancer Research Institute, Seoul National University Children's Hospital) ;
  • Moon, Jin Soo (Department of Pediatrics, Seoul National University Hospital) ;
  • Ko, Jae Sung (Department of Pediatrics, Seoul National University Hospital)
  • Received : 2019.09.30
  • Accepted : 2020.01.28
  • Published : 2020.03.15

Abstract

Giant cell hepatitis with autoimmune hemolytic anemia (AHA) is a rare disease of infancy characterized by the presence of both Coombs-positive hemolytic anemia and progressive liver disease with giant cell transformation of hepatocytes. Here, we report a case involving a seven-month-old male infant who presented with AHA followed by cholestatic hepatitis. The clinical features included jaundice, pallor, and red urine. Physical examination showed generalized icterus and splenomegaly. The laboratory findings suggested warm-type AHA with cholestatic hepatitis. Liver biopsy revealed giant cell transformation of hepatocytes and moderate lobular inflammation. The patient was successfully treated with four doses of rituximab. Early relapse of hemolytic anemia and hepatitis was observed, which prompted the use of an additional salvage dose of rituximab. He is currently in clinical remission.

Keywords

References

  1. Bernard O, Hadchouel M, Scotto J, Odievre M, Alagille D. Severe giant cell hepatitis with autoimmune hemolytic anemia in early childhood. J Pediatr 1981;99:704-11. https://doi.org/10.1016/S0022-3476(81)80388-5
  2. Whitington PF, Vos MB, Bass LM, Melin-Aldana H, Romero R, Roy CC, et al. Humoral immune mechanism of liver injury in giant cell hepatitis with autoimmune hemolytic anemia. J Pediatr Gastroenterol Nutr 2014;58:74-80. https://doi.org/10.1097/MPG.0b013e3182a98dbe
  3. Maggiore G, Sciveres M, Fabre M, Gori L, Pacifico L, Resti M, et al. Giant cell hepatitis with autoimmune hemolytic anemia in early childhood: long-term outcome in 16 children. J Pediatr 2011;159:127-32.e1. https://doi.org/10.1016/j.jpeds.2010.12.050
  4. Gorelik M, Debski R, Frangoul H. Autoimmune hemolytic anemia with giant cell hepatitis: case report and review of the literature. J Pediatr Hematol Oncol 2004;26:837-9.
  5. Cho MH, Park HS, Han HS, Bae SH. Giant cell hepatitis with autoimmune hemolytic anemia in a Korean infant. Pediatr Int 2016;58:628-31. https://doi.org/10.1111/ped.12874
  6. Kashyap R, Sarangi JN, Choudhry VP. Autoimmune hemolytic anemia in an infant with giant cell hepatitis. Am J Hematol 2006;81:199-201. https://doi.org/10.1002/ajh.20414
  7. Rovelli A, Corti P, Beretta C, Bovo G, Conter V, Mieli-Vergani G. Alemtuzumab for giant cell hepatitis with autoimmune hemolytic anemia. J Pediatr Gastroenterol Nutr 2007;45:596-9. https://doi.org/10.1097/MPG.0b013e318033169f
  8. Brichard B, Sokal E, Gosseye S, Buts JP, Gadisseux JF, Cornu G. Coombs-positive giant cell hepatitis of infancy: effect of steroids and azathioprine therapy. Eur J Pediatr 1991;150:314-7. https://doi.org/10.1007/BF01955929
  9. Miloh T, Manwani D, Morotti R, Sukru E, Shneider B, Kerkar N. Giant cell hepatitis and autoimmune hemolytic anemia successfully treated with rituximab. J Pediatr Gastroenterol Nutr 2007;44:634-6. https://doi.org/10.1097/MPG.0b013e31802e9739
  10. Paganelli M, Patey N, Bass LM, Alvarez F. Anti-CD20 treatment of giant cell hepatitis with autoimmune hemolytic anemia. Pediatrics 2014;134:e1206-10. https://doi.org/10.1542/peds.2014-0032
  11. Bakula A, Socha P, Klaudel-Dreszler M, Karolczyk G, Wozniak M, Rutynowska-Pronicka O, et al. Giant cell hepatitis with autoimmune hemolytic anemia in children: proposal for therapeutic approach. J Pediatr Gastroenterol Nutr 2014;58:669-73. https://doi.org/10.1097/MPG.0000000000000270
  12. Weinstein T, Valderrama E, Pettei M, Levine J. Early steroid therapy for the treatment of giant cell hepatitis with autoimmune hemolytic anemia. J Pediatr Gastroenterol Nutr 1993;17:313-6. https://doi.org/10.1097/00005176-199310000-00015
  13. Vajro P, Migliaro F, Ruggeri C, Di Cosmo N, Crispino G, Caropreso M, et al. Life saving cyclophosphamide treatment in a girl with giant cell hepatitis and autoimmune haemolytic anaemia: case report and up-to-date on therapeutical options. Dig Liver Dis 2006;38:846-50. https://doi.org/10.1016/j.dld.2005.09.013
  14. Lega S, Maschio M, Taddio A, Maggiore G, Ventura A. Giant cell hepatitis with Coombs-positive haemolytic anaemia: steroid sparing with high-dose intravenous immunoglobulin and cyclosporine. Acta Paediatr 2013;102:e137-9. https://doi.org/10.1111/apa.12114
  15. Marsalli G, Nastasio S, Sciveres M, Calvo PL, Ramenghi U, Gatti S, et al. Efficacy of intravenous immunoglobulin therapy in giant cell hepatitis with autoimmune hemolytic anemia: a multicenter study. Clin Res Hepatol Gastroenterol 2016;40:83-9. https://doi.org/10.1016/j.clinre.2015.03.009
  16. Imgrueth M, Wagner HP, Pipczynski-Suter K, Beguin L, Wyss M, Pfister AM, et al. Plasma exchange: an important part of the therapeutic procedure in a small child with autoimmune hemolytic anemia. Acta Paediatr Scand 1986;75:1037-41. https://doi.org/10.1111/j.1651-2227.1986.tb10339.x
  17. Akyildiz M, Karasu Z, Arikan C, Nart D, Kilic M. Successful liver transplantation for giant cell hepatitis and Coombs-positive hemolytic anemia: a case report. Pediatr Transplant 2005;9:630-3. https://doi.org/10.1111/j.1399-3046.2005.00346.x
  18. Melendez HV, Rela M, Baker AJ, Ball C, Portmann B, Mieli-Vergani G, et al. Liver transplant for giant cell hepatitis with autoimmune haemolytic anaemia. Arch Dis Child 1997;77:249-51. https://doi.org/10.1136/adc.77.3.249
  19. Unal S, Kuskonmaz B, Balamtekin N, Baysoy G, Aytac Elmas S, Orhan D, et al. Autoimmune hemolytic anemia and giant cell hepatitis: Report of three infants. Turk J Haematol 2010;27:308-13. https://doi.org/10.5152/tjh.2010.55
  20. Raj S, Stephen T, Debski RF. Giant cell hepatitis with autoimmune hemolytic anemia: a case report and review of pediatric literature. Clin Pediatr (Phila) 2011;50:357-9. https://doi.org/10.1177/0009922810379501
  21. Bouguila J, Mabrouk S, Tilouche S, Bakir D, Trabelsi A, Hmila A, et al. Giant cell hepatitis with autoimmune hemolytic anemia in a nine month old infant. World J Hepatol 2013;5:226-9. https://doi.org/10.4254/wjh.v5.i4.226
  22. Perez-Atayde AR, Sirlin SM, Jonas M. Coombs-positive autoimmune hemolytic anemia and postinfantile giant cell hepatitis in children. Pediatr Pathol 1994;14:69-77. https://doi.org/10.3109/15513819409022027
  23. Choulot JJ, Parent Y, Etcharry F, Saint-Martin J, Mensire A. [Giant cell hepatitis and autoimmune hemolytic anemia: efficacy of splenectomy on hemolysis]. Arch Pediatr 1996;3:789-91. https://doi.org/10.1016/0929-693X(96)82162-2
  24. Hadzic N, Portmann B, Lewis I, Mieli-Vergani G. Coombs positive giant cell hepatitis--a new feature of Evans' syndrome. Arch Dis Child 1998;78:397-8.
  25. Hartman C, Berkowitz D, Brik R, Arad A, Elhasid R, Shamir R. Giant cell hepatitis with autoimmune hemolytic anemia and hemophagocytosis. J Pediatr Gastroenterol Nutr 2001;32:330-4. https://doi.org/10.1097/00005176-200103000-00020

Cited by

  1. Infantile giant cell hepatitis with autoimmune hemolytic anemia vol.13, pp.4, 2020, https://doi.org/10.4254/wjh.v13.i4.411